Disease details

臨床試験数 : 29 / 薬物数 : 25 - (DrugBank : 11) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 20

6 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03348644 (ClinicalTrials.gov)	August 1, 2015	9/10/2017	Milk Products in the Treatment of Hypophosphatemic Rickets	Milk Products in the Treatment of Hypophosphatemic Rickets: A Randomised Crossover Trial	Hypophosphatemic Rickets	Dietary Supplement: Phosphate tablets.;Dietary Supplement: High cheese intake.;Dietary Supplement: High milk intake.	University of Aarhus	University of East Anglia;Kolding Sygehus;Aarhus University Hospital	Completed	14 Years	N/A	Female	7	N/A	Denmark
2	JPRN-JapicCTI-101332	01/9/2010	02/11/2010	Therapeutic use of Z-521	Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial rickets, X-linked hypophosphatemia, vitamin D-resistant rickets)	primary hypophosphatemic rickets	Intervention name : Z-521 Dosage And administration of the intervention : 300-3000mg inorganic phosphorus is orally administered in 3 or 4 times per day	Zeria Pharmaceutical Co., Ltd.	NULL		1	14	BOTH	10	Phase 3	NULL
3	NCT01237288 (ClinicalTrials.gov)	September 2010	7/11/2010	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Primary Hypophosphatemic Rickets	Drug: Z-521	Zeria Pharmaceutical	NULL	Completed	1 Year	14 Years	Both	16	Phase 3	Japan
4	NCT01057186 (ClinicalTrials.gov)	December 2009	26/1/2010	Hypophosphatemic Rickets in Norway	Hypophosphatemic Rickets in Norway	Hypophosphatemia, Familial;Rickets;Hyperphosphatemia	Dietary Supplement: Alfacalcidol; phosphate .;Drug: Sevelamer	Haukeland University Hospital	NULL	Active, not recruiting	N/A	N/A	Both	80	N/A	Norway
5	ChiCTR-OOC-16010095	2006-01-01	2016-12-07	Oral Phosphate Supplements Play an Important Role in Improving the Bone Mineral Density of Hypophosphatemic Osteomalacia Patients	Effect of Phosphate on hypophosphatemia	Hypophosphatemic Osteomalacia	A1:received phosphate solution doses at a frequency dependent upon measured serum phosphorus levels;A2:received phosphate solution doses only every three to four days;A3:received no phosphate solution;A:Hypophosphatemic Osteomalacia;B:Control;	The Second Xiangya Hospital, Central South University	NULL	Completed			Both	A1:3;A2:5;A3:3;A:21;B:105;		China
6	NCT00195936 (ClinicalTrials.gov)	June 2005	13/9/2005	Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets	Effect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic Rickets	Hypophosphatemic Rickets, X-Linked Dominant	Drug: Cinacalcet	Children's Mercy Hospital Kansas City	NULL	Completed	5 Years	N/A	All	8	Phase 1	United States

先頭へ